Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor–refractory multiple myeloma
ContributorsDriessen, Christoph; Müller, Rouven; Novak, Urban; Cantoni, Nathan; Betticher, Daniel; Mach, Nicolas; Rüfer, Axel; Mey, Ulrich; Samaras, Panagiotis; Ribi, Karin; Besse, Lenka; Besse, Andrej; Berset, Catherine; Rondeau, Stephanie; Hawle, Hanne; Hitz, Felicitas; Pabst, Thomas; Zander, Thilo
Published inBlood, vol. 132, no. 19, p. 2097-2100
Publication date2018
Keywords
- Bortezomib
- Dexamethasone
- Multiple myeloma
- Nelfinavir
- Proteasome inhibitors
Affiliation entities
Research groups
Citation (ISO format)
DRIESSEN, Christoph et al. Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor–refractory multiple myeloma. In: Blood, 2018, vol. 132, n° 19, p. 2097–2100. doi: 10.1182/blood-2018-05-851170
Main files (1)
Article (Published version)
Secondary files (1)
Appendix
Identifiers
- PID : unige:155809
- DOI : 10.1182/blood-2018-05-851170
- PMID : 30237154
Additional URL for this publicationhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238158/
Journal ISSN0006-4971
